Stability-indicating liquid chromatographic method for valacyclovir

International Journal of ChemTech Research

Volumn 1, Issue 3, 2009, Pages 702-708

  Srinivasa Rao, K ^a   Sunil, M ^a  

^a ROLAND INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Recovery studies; RP HPLC; Stress studies; Valacyclovir

Indexed keywords

ACETONITRILE; PHOSPHATE; VALACICLOVIR;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG STABILITY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHOTODEGRADATION; PHOTOOXIDATION; TABLET FORMULATION;

EID: 77953370054     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Moffat C., Osselton M.D. and Widdop B., Clarks Analysis of Drugs and Poisons, 3rd ed. London, Pharmaceutical Press, 2004.
2. Martindale., The Complete Drug Reference, 33rd ed. London, Pharmaceutical Press, 1999.
3. Weller S. and Blum R. and Doucette M., Pharmacokinetics of the acyclovir pro-drug valacyclovir after escalating single- and multipledose administration to normal volunteers, Clin. Pharmacol. Ther., 1993;54:595-605.
4. Jadhava A.S., Patharea D.B. and Shingare M.S., Development and validation of enantioselective high performance liquid chromatographic method for valacyclovir, an antiviral drug in drug substance, J. Pharm. Biomed. Anal., 2007,43(4),1568-72.
5. Palacios M.L., Demasi G., Pizzorno M.T. and Segall A.I., Validation of an HPLC Method for the Determination of Valacyclovir in Pharmaceutical Dosage, J. Liq. Chromatogr. Rel.Technol., 2005, 28 (5), 751 - 62.
6. Maria K., Evagelos G., Sofia G., Michael K. and Irene P., Selective and rapid liquid chromatography/negative-ion electrospray ionization mass spectrometry method for the quantification of valacyclovir and its metabolite in human plasma, J.Chromatogr B 2008, 864(1-2), 78-86.
7. Ayhan S., Cansel K.Z., Yalin Z., Bengi U. and Sibel A.Z., Development and validation of an RPHPLC method for the determination of valacyclovir in tablets and human serum and its application to drug dissolution studies. J. Liq. Chromatogr. Rel. Technol., 2003, 26 (11), 1755-67.
8. Chuong P.H, Fotoula S., Pierre S., Jean-Michel S., Sophie P. and Catherine G., Rapid determination of valacyclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elution., J. Chromatogr. B. Biomed. Sci. Appl., 1999, 732 (1), 47-53.
9. Raja Rajeswari K., Nageswararao P., Sankar G.G., Rao AL., Raju D.B. and Rao J.V.L.N.S., Estimation of valacyclovir in tablets and human serum by RPHPLC method, Asian J Chem 2006;18:2515-18.
10. Jan L. and Clas M., Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir. Antimicrob, Agents. Chemother., 2003, 47, 2438-41.
11. Srinu babu G., Sarat babu I., Kiran kumar N., Yugandhar N.M., Raju C.H.A.I., Spectrophotometric determination of valacyclovir in pharmaceutical formulation, Asian. J. Chem., 2007,19(2),1642-44.
12. Palacios M. L., Demasi G., Pizzorno M. T. and Segall A. I., Validation of an HPLC method for the determination of valaciclovir in pharmaceutical dosage, Journal of Liquid chromatography & related technologies., 2005, 28(5), 751-762
13. Patil1 G. D., Yeole P. G., Manisha P and Wadher S. J., A validated specific reverse phase liquid chromatographic method for the determination of valacyclovir in the presence of its degradation products in bulk drug and in tablet dosage form, International Journal of Chem Tech Research., 2009,1(1), 16-26
14. Fish D.N., Vidaurri V.A and Deeter R.G., Stability of valacyclovir hydrochloride in extemporaneously prepared oral liquids, American Journal of Health-System Pharmacy., 1999, 56 (19), 1957-1960
15. ICH, Stability Testing of New Drug Substances and Products; International Conference on Harmonization., IFPMA, Geneva, 2003.